// App-Quantinova.ai

73 : Barriers to biologic dose tapering in rheumatoid arthritis

Researchers

Presenter

  • Jayne Little

Principal Investigators

  • Ben Parker

  • Sharon Christy-Kilner

  • Christopher Astbury

  • Jill Firth

  • Rebecca Heaton

  • Victoria Hoskins

  • Audrey Low

  • Dipak Roy

  • Surabhi Wig

  • Sahena Haque

Medical Centers

  • Kellgren Centre for Rheumatology, Manchester Royal Infirmary, Manchester University Foundation Trust, Manchester, UK, Manchester, UNITED KINGDOM

  • Department of Pharmacy, Pennine Acute Trust, Manchester, UNITED KINGDOM

  • Department of Rheumatology, Pennine MSK Partnership Ltd, Oldham, UNITED KINGDOM

  • Department of Rheumatology, Stockport NHS Foundation Trust, Manchester, UNITED KINGDOM

  • Department of Rheumatology, Salisbury NHS Foundation Trust, Salisbury, UNITED KINGDOM

  • Rheumatology Department, Tameside and Glossop Integrated Care NHS Foundation Trust, Manchester, UNITED KINGDOM

  • Department of Rheumatology, Stockport NHS Foundation Trust, Manchester, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Prednisolone

  • Hydroxyzine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved